P-24 A prospective phase 1b dose de-escalation open-label clinical study to evaluate the safety and efficacy of sorafenib with metformin and atorvastatin in advanced hepatocellular carcinoma (SMASH)
Titel:
P-24 A prospective phase 1b dose de-escalation open-label clinical study to evaluate the safety and efficacy of sorafenib with metformin and atorvastatin in advanced hepatocellular carcinoma (SMASH)
Auteur:
Bhargava, P. Ostwal, V. Ramaswamy, A. Srinivas, S. Mandavkar, S. Naughane, D. Gota, V. Patkar, S. Goel, M. Banavali, S. Shetty, N.